| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Axsome Therapeutics, Inc. (AXSM) has 9 insiders with recent SEC Form 4 filings, including 3 buys and 18 sells. AXSM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 58.4K | $14.11M | -572 | |
| Dir | 30.4K | $7.34M | -18,180 | |
| CEO | 24.1K | $5.82M | - | |
| Other | 23.7K | $5.73M | - | |
| Dir | 11.4K | $2.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 45,384 | $119.38 | $5,418,059.86 | -67.7% | +44.8% | - | |
| Sep 22, 2025 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 10,000 | $115.96 | $1,159,600.00 | -100% | +31.7% | - | |
| Sep 16, 2025 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 45,783 | $114.48 | $5,241,126.77 | -100% | +28.2% | - | |
| Sep 16, 2025 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 62,880 | $117.08 | $7,361,891.31 | -74.4% | +28.2% | - | |
| Sep 8, 2025 | Coleman Mark | Director | Buy | 1,575 | $127.28 | $200,466.30 | +1.1% | +14.1% | - | |
| Sep 5, 2025 | Saad Mark E50 | Director | Sale+OE | 9,127 | $125.07 | $1,141,513.89 | -47.7% | +18.3% | - | |
| Sep 2, 2025 | Jeffs Roger66 | Director | Sell | 13,464 | $123.68 | $1,665,227.52 | -19.0% | +20.7% | - | |
| Aug 29, 2025 | Jeffs Roger66 | Director | Sell | 60,000 | $121.72 | $7,303,400.00 | -18.0% | +24.9% | - | |
| Aug 26, 2025 | Jeffs Roger66 | Director | Sell | 36,694 | $120.05 | $4,405,215.52 | -11.5% | +24.8% | - | |
| Jun 23, 2025 | Murdock Hunter R. | General Counsel | Sale+OE | 13,514 | $101.42 | $1,370,646.68 | -100% | +15.6% | +146.4% |